Company / AR per Share
INOVIO PHARMACEUTICALS, INC. AR per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.05
FY2024
5-year range
$0.01 / $0.05
FY2020-FY2024
Trend
-
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
AR per Share changed +572% YoY in FY2024, a notable deviation from the 7-year average annual change of +380%.
Based on SEC 10-K filings.
0.05 in FY2024 with a 5-year CAGR of +48.8%.
Improved from $0.03 to $0.05 over the past 3 years.
AR per Share over time
Growth rates
- 3-Year CAGR
- +21.6%
- 5-Year CAGR
- +48.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- Peak ar per share was recorded in FY2016.
- Lowest ar per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0.05 | - |
| FY2023 | - | - |
| FY2022 | $0.01 | -73.2% |
| FY2021 | $0.03 | -84.0% |
| FY2020 | $0.18 | +2443.0% |
| FY2019 | $0.01 | -80.4% |
| FY2018 | $0.04 | -54.7% |
| FY2017 | $0.08 | -63.0% |
| FY2016 | $0.22 | +81.5% |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026